Please Wait.....
Report
Pediatric Neurology Device Market By Product Type (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, Others), By Condition (Stroke, Seizures, Hydrocephalus, Oncology, Others), By Age group (0-5 Years, 5-10 Years, 10-15 Years), By End User (Hospitals, Ambulatory surgery centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2023-01-01 I 220 Pages I Allied Market Research
The pediatric neurology device market valued for $2,764.90 million in 2021 and is projected to reach $5,842.62 million by 2031, registering a CAGR of 7.8% from 2022 to 2031.
Pediatric neurology is a specialized branch of medicine that is known to deal with management and diagnosis of neurological conditions in newborns, infants, children, and adolescents. The discipline of pediatric neurology encompasses disorders and diseases of the brain, spinal cord, autonomic nervous system (ANS), peripheral nervous system (PNS), blood vessels, and muscles that affect a child's nervous system. Most common conditions that pediatric neurologists deal with vary from cerebral palsy or migraines to rare and more complex conditions such as neurodegenerative disorders. In addition, a huge number of patients treated in pediatric neurology have learning difficulties, developmental problems, and epilepsy.
The growth of the pediatric neurology device market is driven by surge in incidence of neurological diseases, prevalence of epilepsy and migraines in children and rise in number of advanced product launches. Moreover, large medical technology firms all over the world are increasingly focusing on acquiring companies that provide devices for neurological disease, which is expected to notably contribute toward the market growth. For instance, in July 2022, France-based investment firm ArchiMed has completed the acquisition of US-based neurodiagnostic devices provider Natus Medical for a total consideration of $1.2 billion. Furthermore, the global pediatric neurology device market growth is largely driven by factors such as increase in significant applications of neurological devices in pediatric patients, various initiatives & funding from government & private bodies for large-scale pediatric neurological diseases study projects and decline in cost of treatment. Prominent players in the global pediatric neurology device market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in pediatric neurology device to strengthen their position in the market and sustain the competitive environment.
However, the high cost of neurological disease treatment restricts the market growth. Conversely, various technological advancements such as the development of new and advanced devices for neurological disease treatment and increase in the patient admission in the hospitals are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The pediatric neurology device market is segmented based on product, age group, condition, end user and region. On the basis of product, the market is categorized into neurostimulator devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid (CSF) management devices and others. On the basis of age group, the market is classified into 0-1 year, 1-5 years, 5-10 years, above 10 years. On the basis of condition, the market is classified into stroke, seizures, hydrocephalus, oncology and others. On the basis of end user, the market is classified into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings KARL STORZ SE & Co. KG., LivaNova PLC, Medtronic plc, Natus Medical Incorporated (ArchiMed), Stryker Corporation, Zimmer Biomet.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pediatric neurology device market analysis from 2021 to 2031 to identify the prevailing pediatric neurology device market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the pediatric neurology device market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global pediatric neurology device market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Neurostimulation Devices
- Neurosurgery Devices
- Interventional Neurology Devices
- Cerebrospinal Fluid Management Devices
- Others
By Condition
- Stroke
- Seizures
- Hydrocephalus
- Oncology
- Others
By Age group
- 0-5 Years
- 5-10 Years
- 10-15 Years
By End User
- Hospitals
- Ambulatory surgery centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Integra LifeSciences Holdings
- B.Braun SE
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Natus Medical Incorporated
- Abbott Laboratories
- KARL STORZ SE & Co. KG
- Zimmer Biomet Holding Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of neurological disorders in children
3.4.1.2. Increase in government funding to support development activities for invention of new medical devices
3.4.1.3. Changing lifestyles led by growing industrialization and urbanization
3.4.2. Restraints
3.4.2.1. High cost associated with diagnosis and treatment monitoring of neurological disorders
3.4.3. Opportunities
3.4.3.1. Rise in awareness regarding the benefits of pediatric neurology devices
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurostimulation Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Neurosurgery Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Interventional Neurology Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Cerebrospinal Fluid Management Devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION
5.1. Overview
5.1.1. Market size and forecast
5.2. Stroke
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Seizures
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Hydrocephalus
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Oncology
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. 0-5 Years
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. 5-10 Years
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. 10-15 Years
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Ambulatory surgery centers
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PEDIATRIC NEUROLOGY DEVICE MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Condition
8.2.4. Market size and forecast, by Age group
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Condition
8.2.6.1.4. Market size and forecast, by Age group
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Condition
8.2.6.2.4. Market size and forecast, by Age group
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Condition
8.2.6.3.4. Market size and forecast, by Age group
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Condition
8.3.4. Market size and forecast, by Age group
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Condition
8.3.6.1.4. Market size and forecast, by Age group
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Condition
8.3.6.2.4. Market size and forecast, by Age group
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Condition
8.3.6.3.4. Market size and forecast, by Age group
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Condition
8.3.6.4.4. Market size and forecast, by Age group
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Condition
8.3.6.5.4. Market size and forecast, by Age group
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Condition
8.3.6.6.4. Market size and forecast, by Age group
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Condition
8.4.4. Market size and forecast, by Age group
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Condition
8.4.6.1.4. Market size and forecast, by Age group
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. Japan
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Condition
8.4.6.2.4. Market size and forecast, by Age group
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Condition
8.4.6.3.4. Market size and forecast, by Age group
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Condition
8.4.6.4.4. Market size and forecast, by Age group
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Condition
8.4.6.5.4. Market size and forecast, by Age group
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Condition
8.4.6.6.4. Market size and forecast, by Age group
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Condition
8.5.4. Market size and forecast, by Age group
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Condition
8.5.6.1.4. Market size and forecast, by Age group
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Condition
8.5.6.2.4. Market size and forecast, by Age group
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Condition
8.5.6.3.4. Market size and forecast, by Age group
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Condition
8.5.6.4.4. Market size and forecast, by Age group
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Integra LifeSciences Holdings
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. B.Braun SE
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Medtronic plc
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Natus Medical Incorporated
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Stryker Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Boston Scientific Corporation
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Abbott Laboratories
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. LivaNova PLC
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Zimmer Biomet Holding Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. KARL STORZ SE & Co. KG
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSURGERY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. PEDIATRIC NEUROLOGY DEVICE MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 05. PEDIATRIC NEUROLOGY DEVICE MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 08. PEDIATRIC NEUROLOGY DEVICE MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 09. PEDIATRIC NEUROLOGY DEVICE MARKET FOR SEIZURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. PEDIATRIC NEUROLOGY DEVICE MARKET FOR HYDROCEPHALUS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. PEDIATRIC NEUROLOGY DEVICE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 14. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 0-5 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 5-10 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 10-15 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 18. PEDIATRIC NEUROLOGY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. PEDIATRIC NEUROLOGY DEVICE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 20. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. PEDIATRIC NEUROLOGY DEVICE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 24. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 25. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 29. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 30. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 33. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 34. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 37. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 38. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 42. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 44. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 46. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 47. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 51. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 54. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 55. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 60. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 62. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 63. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 69. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 70. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 71. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 72. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 73. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 75. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 76. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 79. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 80. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 82. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 83. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 84. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 85. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 86. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 87. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 88. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 91. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 92. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 93. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 94. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 95. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 96. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 97. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 98. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 99. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 100. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 101. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 102. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 103. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 104. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 105. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 107. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 108. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 109. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 110. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 111. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 112. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 113. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 114. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 115. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 116. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 117. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 118. INTEGRA LIFESCIENCES HOLDINGS: KEY EXECUTIVES
TABLE 119. INTEGRA LIFESCIENCES HOLDINGS: COMPANY SNAPSHOT
TABLE 120. INTEGRA LIFESCIENCES HOLDINGS: PRODUCT SEGMENTS
TABLE 121. INTEGRA LIFESCIENCES HOLDINGS: PRODUCT PORTFOLIO
TABLE 122. INTEGRA LIFESCIENCES HOLDINGS: KEY STRATERGIES
TABLE 123. B.BRAUN SE: KEY EXECUTIVES
TABLE 124. B.BRAUN SE: COMPANY SNAPSHOT
TABLE 125. B.BRAUN SE: PRODUCT SEGMENTS
TABLE 126. B.BRAUN SE: PRODUCT PORTFOLIO
TABLE 127. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 128. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 129. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 130. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 131. MEDTRONIC PLC: KEY STRATERGIES
TABLE 132. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 133. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 134. NATUS MEDICAL INCORPORATED: PRODUCT SEGMENTS
TABLE 135. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 136. NATUS MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 137. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 138. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 139. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 140. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 141. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 142. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 143. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 144. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 145. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 146. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 147. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 148. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 149. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 150. LIVANOVA PLC: KEY EXECUTIVES
TABLE 151. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 152. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 153. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 154. LIVANOVA PLC: KEY STRATERGIES
TABLE 155. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 156. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 157. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
TABLE 158. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 159. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
TABLE 160. KARL STORZ SE & CO. KG: KEY EXECUTIVES
TABLE 161. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
TABLE 162. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
TABLE 163. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN PEDIATRIC NEUROLOGY DEVICE MARKET (2022-2031)
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPEDIATRIC NEUROLOGY DEVICE MARKET
FIGURE 10. PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSTIMULATION DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSURGERY DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
FIGURE 16. PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR STROKE, BY COUNTRY 2021-2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR SEIZURES, BY COUNTRY 2021-2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR HYDROCEPHALUS, BY COUNTRY 2021-2031(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
FIGURE 22. PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR 0-5 YEARS, BY COUNTRY 2021-2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR 5-10 YEARS, BY COUNTRY 2021-2031(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR 10-15 YEARS, BY COUNTRY 2021-2031(%)
FIGURE 26. PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021-2031(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
FIGURE 30. PEDIATRIC NEUROLOGY DEVICE MARKET BY REGION, 2021
FIGURE 31. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 32. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 33. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 34. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 35. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 36. UK PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 37. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 38. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 39. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 40. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 41. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 42. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 43. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 44. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 45. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 46. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 47. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 48. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 49. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 54. COMPETITIVE DASHBOARD
FIGURE 55. COMPETITIVE HEATMAP: PEDIATRIC NEUROLOGY DEVICE MARKET
FIGURE 56. TOP PLAYER POSITIONING, 2021
FIGURE 57. INTEGRA LIFESCIENCES HOLDINGS: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 58. INTEGRA LIFESCIENCES HOLDINGS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
FIGURE 59. INTEGRA LIFESCIENCES HOLDINGS: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 60. INTEGRA LIFESCIENCES HOLDINGS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 61. B.BRAUN SE: NET SALES, 2019-2021 ($MILLION)
FIGURE 62. B.BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 63. B.BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 64. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 65. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. NATUS MEDICAL INCORPORATED: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 68. NATUS MEDICAL INCORPORATED: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. NATUS MEDICAL INCORPORATED: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 71. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 72. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 73. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
FIGURE 74. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 75. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 76. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
FIGURE 77. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 78. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 79. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 80. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 81. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 82. ZIMMER BIOMET HOLDING INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 83. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 84. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security